MRK
Merck & Co., Inc.
- Diluted EPS, 2025
- $7.28
- YoY, 2025
- +8.0%
- 5-year CAGR
- +21.2%
- 10-year CAGR
- +16.7%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $7.28 | +8.0% |
| 2024 | $6.74 | +4,714.3% |
| 2023 | $0.14 | −97.5% |
| 2022 | $5.71 | +11.1% |
| 2021 | $5.14 | +84.9% |
| 2020 | $2.78 | −27.0% |
| 2019 | $3.81 | +64.2% |
| 2018 | $2.32 | +166.7% |
| 2017 | $0.87 | −38.3% |
| 2016 | $1.41 | −9.6% |
| 2015 | $1.56 | −61.7% |
| 2014 | $4.07 | +176.9% |
| 2013 | $1.47 | −26.5% |
| 2012 | $2.00 | −1.0% |
| 2011 | $2.02 | +621.4% |
| 2010 | $0.28 | −95.0% |
| 2009 | $5.65 | +55.6% |
| 2008 | $3.63 | +143.6% |
| 2007 | $1.49 | — |